Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Vaccinogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011814
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaccinogen Inc (Vaccinogen) is an immunotherapy company that develops products for the treatment of solid tumors. The company provides oncovax products. It provides immunotherapy products to treat solid tumors and commercializes autologous tumor vaccine products. Vaccinogen’s products are used in the treatment of cancer, infectious disease, autoimmune and anti-inflammatory diseases. The company also discovers, develops and manufactures fully human monoclonal antibodies for human clinical use. It conducts research and development on oncovax for potential uses against other solid tumors, and others. Vaccinogen is headquartered in Baltimore, Maryland, the US.

Vaccinogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vaccinogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vaccinogen Raises USD0.6 Million in Financing Round 10
Vaccinogen Raises US$6.6 Million In Venture Financing 11
Vaccinogen Raises USD2 Million in Financing Round 12
Equity Offering 13
Vaccinogen Raises USD10 Million in Second Tranche of Private Placement of Units 13
Vaccinogen Inc – Key Competitors 14
Vaccinogen Inc – Key Employees 15
Vaccinogen Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Vaccinogen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vaccinogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vaccinogen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Vaccinogen Raises USD0.6 Million in Financing Round 10
Vaccinogen Raises US$6.6 Million In Venture Financing 11
Vaccinogen Raises USD2 Million in Financing Round 12
Vaccinogen Raises USD10 Million in Second Tranche of Private Placement of Units 13
Vaccinogen Inc, Key Competitors 14
Vaccinogen Inc, Key Employees 15

★海外企業調査レポート[Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cox Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Cox Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cox Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Matica Technologies AG:企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also devel …
  • Sinohydro Corporation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Sinohydro Corporation Co., Ltd (Sinohydro) a subsidiary ofPower Construction Corporation of Chinais a global engineering and construction company. It is a state-owned hydropower project contractor with focus on the development of residential, commercial, and industrial properties across the …
  • PriceSmart Inc (PSMT):企業の財務・戦略的SWOT分析
    PriceSmart Inc (PSMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Singapore Airlines Ltd:企業の戦略・SWOT・財務情報
    Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Edge Therapeutics Inc (EDGE)-製薬・医療分野:企業M&A・提携分析
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, …
  • Accelerate Diagnostics Inc (AXDX):企業の財務・戦略的SWOT分析
    Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Austevoll Seafood Asa
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Insight Genetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Insight Genetics Inc (Insight Genetics) is a molecular diagnostic company which discovers, develops and commercializes companion diagnostics. The company offers assays for triple negative breast cancer; and a suite of molecular tests including anaplastic lymphoma kinase (ALK), ROS1 and RET f …
  • Hubbell Incorporated:企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ABM Industries Incorporated (ABM):企業の財務・戦略的SWOT分析
    ABM Industries Incorporated (ABM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ConAgra Foods Inc:戦略・SWOT・企業財務分析
    ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report Summary ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • GRI Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for live …
  • IMI Plc (IMI):石油・ガス:M&Aディール及び事業提携情報
    Summary IMI Plc (IMI) is a manufacturer of valve and fluid technology solutions. The company designs, manufactures and services engineered products that control the precise movement of fluids. It offers critical flow control solutions that enable energy and process industries to operate safely and e …
  • BBB Technologies Inc:企業の製品パイプライン分析2018
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. The company discovers and develops single-drop and mobile integrated diagnostic tool …
  • China Railway Group Ltd:戦略・SWOT・企業財務分析
    China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆